A Phase II Study Using the Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in Patients With Metastatic Cancer
This study tests a personalized treatment for advanced cancers where standard therapies have not worked. Researchers take your white blood cells, update them in a lab to target your specific tumor, and return them to help your body fight the cancer.
You may be eligible if you have certain types of advanced solid tumors that have spread and have not responded to standard treatments. You must also meet specific health requirements and not have active infections or certain other conditions.
You will undergo screening tests and give blood cells through a special procedure called leukapheresis. After your cells are modified in the lab, you will stay in the hospital to receive the modified cells along with supportive medications.
This study is currently recruiting participants in Bethesda, Maryland, United States.
- 1Uses your own modified immune cells to fight your cancer
- 2Involves a hospital stay for treatment and recovery
- 3Requires regular follow-up visits over the course of several years
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.